A kind of Gechen capsule

A technology of Gechen capsules and capsules, applied in the directions of capsule delivery, drug combination, plant/algae/fungus/moss components, etc., can solve problems such as insufficient treatment of benign prostatic hyperplasia, achieve good anti-prostatic hyperplasia, relieve symptoms of patients, prevent The effect of the development of the disease
CN105983080BActive Publication Date: 2019-08-30杭州佛莲生物技术有限公司
1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
杭州佛莲生物技术有限公司
Publication Date
2019-08-30

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses radix puerariae and dried orange peel capsules. The radix puerariae and dried orange peel capsules consist of the following raw materials in parts by weight: 4-13 parts of pangolin scales, 2-6 parts of rhizoma curcumae, 2-6 parts of hirudo, 5-15 parts of radix puerariae, 2-8 parts of radix scutellariae, 2-15 parts of dried orange peel, 2-16 parts of semen hoveniae, 3-20 parts of concha ostreae, 0.5-5 parts of talcum and 0.5-6 parts of cortex cinnamomi. With the application of the radix puerariae and dried orange peel capsules disclosed by the invention, the weight and volume of prostate glands can be reduced and a lecithin drop density in prostatic fluid can be recovered; therefore, the radix puerariae and dried orange peel capsules are excellent in effect on resisting benign prostatic hyperplasia. The radix puerariae and dried orange peel capsules disclosed by the invention can prevent the development of diseases; and in addition, the radix puerariae and dried orange peel capsules can relieve symptoms in patients.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of traditional Chinese medicines, in particular to a Gechen capsule. Background technique

[0002] The pathogenesis of human benign prostate hyperplasia (BPH) has been studied a lot, but its exact etiology has not yet been fully elucidated. It is known that the presence of testicles and increasing age are two conditions that must be met for benign prostatic hyperplasia. In recent years, with the deepening of basic research, it is believed that benign prostatic hyperplasia is the result of the interaction between prostate epithelial cells and mesenchymal cells, that is, epithelial and mesenchymal cells grow through various cytokines (epidermal growth factor, keratinizing growth factor, acidic fibroblasts). Factors, transforming growth factors, etc.) to promote epithelial and mesenchymal hyperplasia.

[0003] At present, the methods for treating hyperplasia of the prostate include drug therapy and surgical treatment. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More